The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
- PMID: 28838177
- PMCID: PMC5853811
- DOI: 10.1093/infdis/jiw602
The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
Abstract
This analysis describes an innovative and successful approach to risk identification and mitigation in relation to the switch from trivalent to bivalent oral polio vaccine (OPV) in the 11 countries of the World Health Organization's (WHO's) South-East Asia Region (SEAR) in April 2016.The strong commitment of governments and immunization professionals to polio eradication and an exemplary partnership between the WHO, United Nations Children's Fund (UNICEF), and other partners and stakeholders in the region and globally were significant contributors to the success of the OPV switch in the SEAR. Robust national switch plans were developed and country-specific innovations were planned and implemented by the country teams. Close monitoring and tracking of the activities and milestones through dashboards and review meetings were undertaken at the regional level to ensure that implementation time lines were met, barriers identified, and solutions for overcoming challenges were discussed and implemented.The SEAR was the first WHO Region globally to complete the switch and declare the successful withdrawal of trivalent OPV from all countries on 17 May 2016.A number of activities implemented during the switch process are likely to contribute positively to existing immunization practices and to similar initiatives in the future. These activities include better vaccine supply chain management, improved mechanisms for disposal of vaccination-related waste materials, and a closer collaboration with drug regulators, vaccine manufacturers, and the private sector for immunization-related initiatives.
Keywords: bivalent oral poliovirus vaccine; immunization; switch; trivalent oral poliovirus vaccine.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
Similar articles
-
Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.J Infect Dis. 2017 Jul 1;216(suppl_1):S183-S192. doi: 10.1093/infdis/jiw626. J Infect Dis. 2017. PMID: 28838179 Free PMC article.
-
Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.J Infect Dis. 2017 Jul 1;216(suppl_1):S66-S75. doi: 10.1093/infdis/jiw616. J Infect Dis. 2017. PMID: 28838178 Free PMC article.
-
Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.J Infect Dis. 2017 Jul 1;216(suppl_1):S101-S108. doi: 10.1093/infdis/jiw574. J Infect Dis. 2017. PMID: 28838170 Free PMC article.
-
Polio endgame: the global switch from tOPV to bOPV.Expert Rev Vaccines. 2016 Jun;15(6):693-708. doi: 10.1586/14760584.2016.1140041. Epub 2016 Feb 2. Expert Rev Vaccines. 2016. PMID: 26751187 Review.
-
Polio endgame: the global introduction of inactivated polio vaccine.Expert Rev Vaccines. 2015 May;14(5):749-62. doi: 10.1586/14760584.2015.1001750. Epub 2015 Jan 19. Expert Rev Vaccines. 2015. PMID: 25597843 Review.
Cited by
-
Implementation challenges and real-world impacts of switching pediatric vaccines: A global systematic literature review.Hum Vaccin Immunother. 2023 Dec 31;19(1):2177459. doi: 10.1080/21645515.2023.2177459. Epub 2023 Mar 7. Hum Vaccin Immunother. 2023. PMID: 36880656 Free PMC article.
-
Expected RATE of Vaccine-Associated Paralytic Poliomyelitis: A Simulation Analysis Regarding Transition from the Trivalent to Bivalent Oral Poliovirus Vaccine.Int J Prev Med. 2021 May 27;12:49. doi: 10.4103/ijpvm.IJPVM_293_19. eCollection 2021. Int J Prev Med. 2021. PMID: 34447491 Free PMC article. No abstract available.
-
A multi-pronged scoping review approach to understanding the evolving implementation of the Smallpox and Polio eradication programs: what can other Global Health initiatives learn?BMC Public Health. 2020 Dec 18;20(Suppl 4):1698. doi: 10.1186/s12889-020-09439-1. BMC Public Health. 2020. PMID: 33339517 Free PMC article.
-
Vaccine Hesitancy as a Challenge or Vaccine Confidence as an Opportunity for Childhood Immunisation in India.Infect Dis Ther. 2020 Sep;9(3):421-432. doi: 10.1007/s40121-020-00302-9. Epub 2020 May 23. Infect Dis Ther. 2020. PMID: 32447713 Free PMC article. Review.
-
Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: encompassing transition from the trivalent to bivalent oral poliovirus vaccine.Virusdisease. 2019 Jun;30(2):201-206. doi: 10.1007/s13337-019-00515-8. Epub 2019 Mar 21. Virusdisease. 2019. PMID: 31179357 Free PMC article.
References
-
- Hasman A, Raaijmakers HC, Noble DJ. Inactivated polio vaccine launch in Nepal: a public health milestone. Lancet Glob Health 2014; 2:e627–8. - PubMed
-
- World Health Organization. Polio vaccines—WHO position paper—March 2016. Wkly Epidemiol Rec 2016; 91:145–68. - PubMed
-
- World Health Organization. Report of the South-East Asia Regional Consultation on the Polio Endgame Strategy. Bangkok, Thailand: WHO Regional office for South-East Asia, 2012.
-
- Meeting of the Strategic Advisory Group of Experts on immunization, October 2015—conclusions and recommendations. Wkly Epidemiol Rec 2015; 90:681–700. - PubMed
-
- World Health Organization. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAP III) http://polioeradication.org/wp-content/uploads/2016/12/GAPIII_2014.pdf Accessed 26 October, 2016.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous